Placeholder Banner

BIO Statement: BIO Urges FDA Release of Risk Assessment on Animal Cloning

March 10, 2016

Dear Ms. Tipton, Mr. Kozak and Mr. Suber:

On behalf of the Biotechnology Industry Organization (BIO), I urge the International Dairy Foods Association, the National Milk Products Federation and U.S. Dairy Export Council and their members to join BIO in supporting the U.S. Food and Drug Administration's (FDA's) release of its final risk assessment, which we anticipate will appropriately confirm the safety of livestock cloning. We ask you to join us in encouraging its release as soon as possible.

The new animal tracking program announced today by two of BIO's members, ViaGen and Trans Ova Genetics, is another great step by our industry that will help locate and track animal clones in teh food chain to provide additional information related to associated food products. These efforts will promote a wider variety of choices for th world's food supply, while facilitating smooth trade transactions in the agricultural community and helping to support the legitimate marketing claims.

Download Full Comments Below
Read the letter
Discover More
We write as a coalition of advocates for the startup ecosystem to voice our strong support for the IGNITE American Innovation Act, legislation to support startups through the economic crisis by allowing companies to monetize tax assets generated…
The Biotechnology Innovation Organization (BIO) is pleased to respond to the U.S. Department of Agriculture’s (USDA) Solicitation of Input from Stakeholders on Agricultural Innovations. BIO applauds USDA for taking a proactive approach and seeking…
July 31, 2020 Re: Docket No. FDA–2020-N-0837: Raare Disease Clinical Trial Network; Request for Information. Dear Sir/Madam: The Biotechnology Innovation Organization (BIO) thanks the Food and Drug Administration (FDA or Agency) for the…